Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development

Hum Vaccin Immunother. 2017 Jan 2;13(1):186-189. doi: 10.1080/21645515.2016.1228500. Epub 2016 Sep 20.

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) first emerged in 2003, causing the SARS epidemic which resulted in a 10% fatality rate. The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV. The application of reverse genetics further enabled that characterization of these bat CoVs and the prediction of their potential to cause disease in humans. The knowledge gained from such studies is valuable in the surveillance and preparation of a possible future outbreak caused by a spill-over of these bat SL-CoVs.

Keywords: Bats; Emerging and re-emerging virus; SARS-like coronavirus; Severe acute respiratory syndrome coronavirus; Zoonotic virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chiroptera / virology*
  • Disease Outbreaks*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Reverse Genetics
  • Severe Acute Respiratory Syndrome / epidemiology*
  • Severe Acute Respiratory Syndrome / virology*
  • Severe acute respiratory syndrome-related coronavirus / genetics*
  • Severe acute respiratory syndrome-related coronavirus / immunology
  • Severe acute respiratory syndrome-related coronavirus / isolation & purification
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity
  • Viral Vaccines / immunology*
  • Viral Vaccines / isolation & purification*

Substances

  • Viral Vaccines